Form 4: CME Group Inc. Executive Ken Vroman Reports Stock Sale
SEC Form 4 Filing
Ken Vroman, Chief Transformation Officer of CME Group Inc., reported the sale of 5,066 shares of Common Stock Class A on February 13, 2025.
Summary
- On February 13, 2025, Ken Vroman, the Chief Transformation Officer of CME Group Inc., sold 5,066 shares of Common Stock Class A.
- The sale price was $250 per share.
- Following the transaction, Vroman directly owns 16,715 shares of CME Group Inc. Common Stock Class A.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This is a routine disclosure of a transaction by a company insider, as required by the SEC. It doesn't necessarily reflect a broader trend in the industry.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by shareholders if they interpret it as a lack of confidence in the company's future, although this is a relatively small transaction.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of stock sale transaction |
| 02/14/2025 | Date of report signature |
Keywords
CME Group Inc., Ken Vroman, Form 4, Stock Sale, Chief Transformation Officer, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.